We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Novel Nanofilm May Be Artificial Retina Precursor

By LabMedica International staff writers
Posted on 16 Dec 2014
Researchers have used advanced nanotechnology techniques to develop a light-sensitive film that has potential for future artificial retina applications.

Investigators at the Hebrew University of Jerusalem (Israel) created a semiconductor nanorod-carbon nanotube based platform for wire-free, light induced retina stimulation. More...
A plasma polymerized acrylic acid midlayer was used to achieve covalent conjugation of semiconductor nanorods directly onto neuro-adhesive, three-dimensional carbon nanotube surfaces. The nanofilm transforms visual cues to electric signals, mimicking the function of the photo-sensitive cells in the retina.

The new device, which absorbed light and stimulated neurons without wires or an external power source, was tested on light-insensitive retinas from embryonic chicks.

Results published in the October 28, 2014, online edition of the journal Nano Letters revealed that the implanted nanomembrane stimulated a neuronal response in the embryonic chick embryos following exposure to light.

Contributing author Dr. Uri Banin, professor of chemistry at the Hebrew University of Jerusalem, said, "This is a pioneering work demonstrating the use of highly tailored semiconductor nanocrystals in activation of biomedical functionalities. We hope this can lead to future implementation of this approach in retinal implants."

Related Links:
Hebrew University of Jerusalem


New
Gold Member
Automatic Hematology Analyzer
CF9600
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
New
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.